TherapeuticsMD Inc (TXMD) - Total Liabilities
Based on the latest financial reports, TherapeuticsMD Inc (TXMD) has total liabilities worth $11.23 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore TXMD operating cash flow to assess how effectively this company generates cash.
TherapeuticsMD Inc - Total Liabilities Trend (1994–2024)
This chart illustrates how TherapeuticsMD Inc's total liabilities have evolved over time, based on quarterly financial data. Check TXMD financial resilience to evaluate the company's liquid asset resilience ratio.
TherapeuticsMD Inc Competitors by Total Liabilities
The table below lists competitors of TherapeuticsMD Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CEO Event Medya AS
IS:CEOEM
|
Turkey | TL492.00 Million |
|
Seafresh Industry Public Company Limited
BK:CFRESH
|
Thailand | ฿2.70 Billion |
|
DAIHAN Scientific Co. Ltd
KQ:131220
|
Korea | ₩13.84 Billion |
|
Silvair Inc
WAR:SVRS
|
Poland | zł6.29 Million |
|
JPMorgan American Investment Trust
LSE:JAM
|
UK | GBX102.83 Million |
|
Ropharma Bras
RO:RPH
|
Romania | RON688.42 Million |
Liability Composition Analysis (1994–2024)
This chart breaks down TherapeuticsMD Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TherapeuticsMD Inc (TXMD) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how TherapeuticsMD Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for TherapeuticsMD Inc (1994–2024)
The table below shows the annual total liabilities of TherapeuticsMD Inc from 1994 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $11.45 Million | -18.33% |
| 2023-12-31 | $14.02 Million | -74.65% |
| 2022-12-31 | $55.31 Million | -78.98% |
| 2021-12-31 | $263.09 Million | -13.91% |
| 2020-12-31 | $305.61 Million | +19.01% |
| 2019-12-31 | $256.78 Million | +124.34% |
| 2018-12-31 | $114.46 Million | +759.23% |
| 2017-12-31 | $13.32 Million | -11.09% |
| 2016-12-31 | $14.98 Million | +40.47% |
| 2015-12-31 | $10.67 Million | -0.23% |
| 2014-12-31 | $10.69 Million | +46.08% |
| 2013-12-31 | $7.32 Million | +0.92% |
| 2012-12-31 | $7.25 Million | +130.16% |
| 2011-12-31 | $3.15 Million | +129.14% |
| 2010-12-31 | $1.37 Million | +18.45% |
| 2009-12-31 | $1.16 Million | +3149.59% |
| 2008-12-31 | $35.72K | -54.10% |
| 2007-12-31 | $77.83K | -56.72% |
| 2006-12-31 | $179.83K | -63.54% |
| 2005-12-31 | $493.18K | +1228.79% |
| 2004-12-31 | $37.12K | +15.59% |
| 2003-12-31 | $32.11K | +91.08% |
| 2002-12-31 | $16.80K | -27.06% |
| 2001-12-31 | $23.04K | +42.16% |
| 2000-12-31 | $16.21K | -9.00% |
| 1999-12-31 | $17.81K | -64.89% |
| 1998-12-31 | $50.72K | +626.39% |
| 1997-12-31 | $6.98K | +44.76% |
| 1996-12-31 | $4.82K | -92.52% |
| 1995-12-31 | $64.49K | +462.21% |
| 1994-12-31 | $11.47K | -- |
About TherapeuticsMD Inc
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors an… Read more